Similasan Corp.

Lawsuit Filings

$3.57 Million Settlement Resolves Similasan Eye Drop Class Action Lawsuit

November 13, 2024 Similasan has agreed to pay $3,575,000 to settle a class action that claimed the company illegally marketed eye drops as homeopathic drugs without approval from the FDA.

Class Action Alleges Similasan Eye Drops Illegally Sold as Homeopathic Drugs Without FDA Approval [UPDATE]

September 27, 2023 A proposed class action alleges Similasan has illegally marketed its eye drops as homeopathic drugs capable of curing a range of ophthalmic conditions.